The new rules, spurred by the COVID-19 pandemic and concerns about U.S.-funded studies in Wuhan, China, that manipulated bat viruses distantly related to SARS-CoV-2, will expand the number of studies that must undergo special reviews. But the rules, released yesterday by the Office of Science and Technology Policy (OSTP), are narrower than a proposal floated last year that many scientists feared would complicate studies on low-risk pathogens such as cold viruses and herpesviruses.

https://www.unmc.edu/healthsecurity/transmission/2024/05/07/white-house-overhauls-rules-for-risky-pathogen-studies/